Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
Published on: May 17, 2024
The causal association between liver diseases and vascular dementia: A two-sample Mendelian randomization study
Xianxian Zhang1, Xuefeng Zang2, Pinglei Pan1,3
1Department of Neurology, Affiliated Hospital 6 of Nantong University (Yancheng Third People's Hospital), Yancheng, China.
This study found no direct causal link between liver diseases and vascular dementia (VaD). However, nonalcoholic fatty liver disease (NAFLD) may offer protection against VaD, especially when considering metabolic factors like glucose and triglycerides.
Area of Science:
- Genetics
- Neurology
- Hepatology
Background:
- Vascular dementia (VaD) poses a significant health challenge.
- The relationship between liver diseases and VaD is not fully understood.
- Investigating potential causal links is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the potential causal associations between four liver diseases and vascular dementia (VaD) using a two-sample Mendelian randomization (MR) approach.
- To explore the role of metabolic factors, such as fasting glucose and triglycerides, in the relationship between liver disease and VaD.
Main Methods:
- A two-sample Mendelian randomization (MR) study was conducted using genome-wide association study (GWAS) summary statistics.
- Four liver diseases (NAFLD, NASH, ALD, FACOL) and VaD were analyzed.
- Inverse variance weighted (IVW) analysis was the primary method, supplemented by sensitivity analyses and multivariable MR (MVMR) adjusting for metabolic traits.
Main Results:
- The primary IVW analysis revealed no significant direct causal associations between the studied liver diseases and VaD.
- Sensitivity analyses suggested potential heterogeneity and pleiotropy for nonalcoholic fatty liver disease (NAFLD) and fibrosis/cirrhosis (FACOL).
- Multivariable MR (MVMR) adjusting for fasting glucose or triglycerides indicated a significant protective association of NAFLD against VaD, which was not observed for other liver diseases.
Conclusions:
- There is no direct causal link established between the investigated liver diseases and vascular dementia (VaD).
- Metabolic factors, specifically elevated triglycerides or fasting glucose, may confound the association between NAFLD and VaD.
- Nonalcoholic fatty liver disease (NAFLD) may have a protective effect against VaD, underscoring the importance of metabolic health in dementia risk.
More Related Videos
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...